Author:
Aryankalayil Molykutty J.,Bylicky Michelle A.,Martello Shannon,Chopra Sunita,Sproull Mary,May Jared M.,Shankardass Aman,MacMillan Laurel,Vanpouille-Box Claire,Dalo Juan,Scott Kevin M. K.,Norman Coleman C.
Abstract
AbstractRadiation injury from medical, accidental, or intentional sources can induce acute and long-term hepatic dysregulation, fibrosis, and cancer. This long-term hepatic dysregulation decreases quality of life and may lead to death. Our goal in this study is to determine acute changes in biological pathways and discover potential RNA biomarkers predictive of radiation injury. We performed whole transcriptome microarray analysis of mouse liver tissue (C57BL/6 J) 48 h after whole-body irradiation with 1, 2, 4, 8, and 12 Gray to identify significant expression changes in mRNAs, lncRNAs, and miRNAs, We also validated changes in specific RNAs through qRT-PCR. We used Ingenuity Pathway Analysis (IPA) to identify pathways associated with gene expression changes. We observed significant dysregulation of multiple mRNAs across all doses. In contrast, miRNA dysregulation was observed upwards of 2 Gray. The most significantly upregulated mRNAs function as tumor suppressors: Cdkn1a, Phlda3, and Eda2r. The most significantly downregulated mRNAs were involved in hemoglobin synthesis, inflammation, and mitochondrial function including multiple members of Hbb and Hba. The most significantly upregulated miRNA included: miR-34a-5p, miR-3102-5p, and miR-3960, while miR-342-3p, miR-142a-3p, and miR-223-3p were most significantly downregulated. IPA predicted activation of cell cycle checkpoint control pathways and inhibition of pathways relevant to inflammation and erythropoietin. Clarifying expression of mRNA, miRNA and lncRNA at a short time point (48 h) offers insight into potential biomarkers, including radiation markers shared across organs and animal models. This information, once validated in human models, can aid in development of bio-dosimetry biomarkers, and furthers our understanding of acute pathway dysregulation.
Funder
National Institute of Allergy and Infectious Diseases
Publisher
Springer Science and Business Media LLC
Reference125 articles.
1. Montay-Gruel, P., Meziani, L., Yakkala, C. & Vozenin, M. Expanding the therapeutic index of radiation therapy by normal tissue protection. Br. J. Radiol. 92(1093), 20180008 (2019).
2. Kim, J., Jenrow, K. & Brown, S. Mechanisms of radiation-induced normal tissue toxicity and implications for future clinical trials. Radiat. Oncol. J. 32(3), 103–115 (2014).
3. Preston, D. L. et al. Solid cancer incidence in atomic bomb survivors: 1958–1998. Radiat. Res. 168(1), 1–64 (2007).
4. Akahoshi, M. et al. Effects of radiation on fatty liver and metabolic coronary risk factors among atomic bomb survivors in Nagasaki. Hypertens. Res. 26(12), 965–970 (2003).
5. Tanaka, H., Hayashi, S., Ohtakara, K. & Hoshi, H. Hepatic dysfunction after radiotherapy for primary gastric lymphoma. J. Radiat. Res. 54(1), 92–97 (2013).
Cited by
2 articles.
订阅此论文施引文献
订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献